| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 71 | 2024 | 955 | 11.500 |
Why?
|
| Genome-Wide Association Study | 46 | 2023 | 1621 | 5.070 |
Why?
|
| Genetic Predisposition to Disease | 54 | 2022 | 2271 | 4.230 |
Why?
|
| HLA Antigens | 24 | 2019 | 232 | 4.060 |
Why?
|
| Founder Effect | 21 | 2018 | 104 | 3.290 |
Why?
|
| DNA Methylation | 14 | 2023 | 628 | 3.040 |
Why?
|
| Polymorphism, Single Nucleotide | 56 | 2023 | 2357 | 2.810 |
Why?
|
| Histocompatibility Antigens Class I | 15 | 2016 | 203 | 2.730 |
Why?
|
| Alleles | 39 | 2022 | 1128 | 2.550 |
Why?
|
| Genetic Association Studies | 6 | 2023 | 294 | 2.410 |
Why?
|
| Pedigree | 30 | 2019 | 966 | 2.080 |
Why?
|
| Genotype | 35 | 2023 | 1851 | 1.990 |
Why?
|
| Gene Frequency | 24 | 2021 | 677 | 1.820 |
Why?
|
| Quantitative Trait Loci | 22 | 2021 | 576 | 1.740 |
Why?
|
| Epigenesis, Genetic | 12 | 2023 | 479 | 1.620 |
Why?
|
| Polymorphism, Genetic | 14 | 2018 | 819 | 1.610 |
Why?
|
| Child | 39 | 2023 | 6928 | 1.580 |
Why?
|
| Hypersensitivity | 6 | 2024 | 154 | 1.580 |
Why?
|
| HLA-G Antigens | 15 | 2013 | 52 | 1.570 |
Why?
|
| Lung | 7 | 2023 | 1170 | 1.560 |
Why?
|
| Hypersensitivity, Immediate | 8 | 2020 | 62 | 1.540 |
Why?
|
| Haplotypes | 23 | 2021 | 642 | 1.540 |
Why?
|
| Linkage Disequilibrium | 15 | 2020 | 473 | 1.500 |
Why?
|
| Humans | 168 | 2024 | 86645 | 1.470 |
Why?
|
| Genetic Variation | 21 | 2021 | 1351 | 1.470 |
Why?
|
| Quantitative Trait, Heritable | 8 | 2017 | 124 | 1.300 |
Why?
|
| Chromosomes, Human, Pair 17 | 6 | 2021 | 110 | 1.260 |
Why?
|
| Gene Expression Regulation | 14 | 2022 | 1920 | 1.230 |
Why?
|
| Phenotype | 21 | 2023 | 2378 | 1.210 |
Why?
|
| Adult | 62 | 2023 | 25648 | 1.210 |
Why?
|
| Female | 98 | 2023 | 44534 | 1.200 |
Why?
|
| Chromosome Mapping | 19 | 2017 | 1074 | 1.200 |
Why?
|
| Sex Characteristics | 8 | 2021 | 319 | 1.190 |
Why?
|
| Pregnancy | 26 | 2023 | 2894 | 1.170 |
Why?
|
| Premature Birth | 3 | 2023 | 113 | 1.150 |
Why?
|
| Environment | 4 | 2016 | 219 | 1.100 |
Why?
|
| MicroRNAs | 3 | 2021 | 534 | 1.100 |
Why?
|
| Genome, Human | 14 | 2015 | 756 | 1.070 |
Why?
|
| Male | 84 | 2021 | 40967 | 1.030 |
Why?
|
| Integrin beta3 | 6 | 2007 | 30 | 1.030 |
Why?
|
| Epithelial Cells | 7 | 2023 | 669 | 0.970 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2023 | 272 | 0.960 |
Why?
|
| Adolescent | 26 | 2023 | 8982 | 0.950 |
Why?
|
| Abortion, Habitual | 6 | 2015 | 33 | 0.930 |
Why?
|
| Gene Expression Profiling | 9 | 2021 | 1384 | 0.890 |
Why?
|
| Labor, Obstetric | 1 | 2023 | 46 | 0.890 |
Why?
|
| Obstetric Labor, Premature | 1 | 2023 | 58 | 0.880 |
Why?
|
| Models, Genetic | 14 | 2019 | 926 | 0.880 |
Why?
|
| Transcription, Genetic | 4 | 2021 | 1135 | 0.880 |
Why?
|
| Leukocytes | 4 | 2021 | 202 | 0.850 |
Why?
|
| Pre-Eclampsia | 3 | 2012 | 246 | 0.850 |
Why?
|
| Interleukin-13 | 3 | 2016 | 36 | 0.840 |
Why?
|
| South Dakota | 16 | 2015 | 47 | 0.840 |
Why?
|
| Nuclear Family | 4 | 2019 | 92 | 0.800 |
Why?
|
| Fertility | 7 | 2019 | 115 | 0.800 |
Why?
|
| Genetic Linkage | 12 | 2011 | 623 | 0.790 |
Why?
|
| Sequence Deletion | 4 | 2014 | 205 | 0.790 |
Why?
|
| Consanguinity | 6 | 2019 | 73 | 0.780 |
Why?
|
| Chromosomes, Human, Pair 6 | 4 | 2012 | 125 | 0.760 |
Why?
|
| Promoter Regions, Genetic | 8 | 2021 | 937 | 0.760 |
Why?
|
| Nose | 2 | 2020 | 94 | 0.750 |
Why?
|
| Immunity, Mucosal | 3 | 2021 | 69 | 0.740 |
Why?
|
| Microbiota | 4 | 2020 | 381 | 0.730 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2019 | 10 | 0.720 |
Why?
|
| Immunoglobulin E | 9 | 2021 | 144 | 0.710 |
Why?
|
| Respiratory Hypersensitivity | 4 | 2007 | 41 | 0.710 |
Why?
|
| Cardiovascular Diseases | 5 | 2016 | 827 | 0.710 |
Why?
|
| Immunity, Innate | 4 | 2021 | 409 | 0.710 |
Why?
|
| Genetics, Population | 7 | 2012 | 394 | 0.690 |
Why?
|
| Farms | 2 | 2023 | 5 | 0.680 |
Why?
|
| Serotonin | 6 | 2006 | 218 | 0.670 |
Why?
|
| Gene-Environment Interaction | 3 | 2016 | 103 | 0.670 |
Why?
|
| Gene Regulatory Networks | 3 | 2018 | 296 | 0.670 |
Why?
|
| Abortion, Spontaneous | 5 | 2006 | 66 | 0.670 |
Why?
|
| Genomic Imprinting | 1 | 2018 | 33 | 0.670 |
Why?
|
| Immunologic Memory | 1 | 2019 | 152 | 0.660 |
Why?
|
| Rhinitis | 3 | 2023 | 175 | 0.650 |
Why?
|
| Case-Control Studies | 15 | 2021 | 1805 | 0.650 |
Why?
|
| Receptors, IgG | 1 | 2018 | 52 | 0.640 |
Why?
|
| CD3 Complex | 1 | 2018 | 135 | 0.640 |
Why?
|
| CD28 Antigens | 1 | 2018 | 88 | 0.640 |
Why?
|
| Puberty | 1 | 2018 | 59 | 0.640 |
Why?
|
| Sinusitis | 3 | 2023 | 210 | 0.630 |
Why?
|
| Reproduction | 4 | 2015 | 195 | 0.630 |
Why?
|
| Mutation | 10 | 2012 | 3968 | 0.620 |
Why?
|
| Cytokines | 9 | 2021 | 776 | 0.620 |
Why?
|
| Population | 1 | 2017 | 35 | 0.620 |
Why?
|
| RNA, Untranslated | 1 | 2017 | 63 | 0.610 |
Why?
|
| Estrogens | 1 | 2018 | 200 | 0.600 |
Why?
|
| Enhancer Elements, Genetic | 5 | 2021 | 266 | 0.600 |
Why?
|
| Actinobacteria | 1 | 2017 | 11 | 0.600 |
Why?
|
| Th2 Cells | 3 | 2019 | 146 | 0.600 |
Why?
|
| Leukocytes, Mononuclear | 6 | 2022 | 196 | 0.590 |
Why?
|
| Nasopharynx | 1 | 2017 | 47 | 0.590 |
Why?
|
| Young Adult | 15 | 2021 | 5976 | 0.590 |
Why?
|
| Genes, Recessive | 3 | 2015 | 87 | 0.580 |
Why?
|
| Genes, MHC Class I | 4 | 2021 | 48 | 0.580 |
Why?
|
| Neoplasm Proteins | 6 | 2022 | 532 | 0.570 |
Why?
|
| Middle Aged | 28 | 2021 | 25028 | 0.570 |
Why?
|
| Genetic Testing | 5 | 2012 | 535 | 0.570 |
Why?
|
| Immunophenotyping | 4 | 2019 | 211 | 0.570 |
Why?
|
| Antibodies | 1 | 2018 | 350 | 0.560 |
Why?
|
| Lipids | 1 | 2017 | 269 | 0.560 |
Why?
|
| Parents | 1 | 2019 | 272 | 0.550 |
Why?
|
| Lymph Nodes | 1 | 2019 | 533 | 0.550 |
Why?
|
| Agriculture | 2 | 2016 | 38 | 0.540 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2006 | 109 | 0.540 |
Why?
|
| Allergens | 7 | 2023 | 179 | 0.540 |
Why?
|
| Rural Population | 2 | 2017 | 136 | 0.530 |
Why?
|
| Transcriptome | 6 | 2021 | 580 | 0.530 |
Why?
|
| Infant, Newborn | 12 | 2023 | 2379 | 0.520 |
Why?
|
| DNA, Mitochondrial | 3 | 2012 | 183 | 0.520 |
Why?
|
| Chromosome Disorders | 2 | 2012 | 114 | 0.510 |
Why?
|
| Pore Forming Cytotoxic Proteins | 3 | 2022 | 54 | 0.490 |
Why?
|
| Interferon-gamma | 2 | 2018 | 444 | 0.490 |
Why?
|
| Genetic Carrier Screening | 2 | 2011 | 60 | 0.480 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 3 | 2010 | 57 | 0.470 |
Why?
|
| Genetic Loci | 8 | 2022 | 250 | 0.470 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 1 | 2013 | 8 | 0.470 |
Why?
|
| beta-Defensins | 1 | 2013 | 12 | 0.470 |
Why?
|
| Microsatellite Repeats | 6 | 2008 | 145 | 0.470 |
Why?
|
| Respiratory Mucosa | 3 | 2020 | 88 | 0.470 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 37 | 0.470 |
Why?
|
| Chemokines, CC | 1 | 2013 | 34 | 0.470 |
Why?
|
| Risk Factors | 15 | 2023 | 5417 | 0.460 |
Why?
|
| Aged | 18 | 2021 | 18415 | 0.460 |
Why?
|
| Heterozygote | 6 | 2018 | 365 | 0.460 |
Why?
|
| Gene Expression | 7 | 2021 | 1284 | 0.450 |
Why?
|
| Chimerism | 1 | 2013 | 37 | 0.450 |
Why?
|
| HLA-DQ beta-Chains | 5 | 2021 | 12 | 0.450 |
Why?
|
| Bronchial Hyperreactivity | 4 | 2020 | 77 | 0.440 |
Why?
|
| Genome, Mitochondrial | 1 | 2012 | 26 | 0.430 |
Why?
|
| Trophoblasts | 4 | 2021 | 33 | 0.420 |
Why?
|
| Rhinovirus | 4 | 2023 | 25 | 0.420 |
Why?
|
| Respiration | 1 | 2013 | 262 | 0.410 |
Why?
|
| Obesity | 4 | 2021 | 963 | 0.410 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2011 | 4 | 0.410 |
Why?
|
| Sex Factors | 8 | 2014 | 1054 | 0.410 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2011 | 24 | 0.400 |
Why?
|
| Bayes Theorem | 3 | 2022 | 361 | 0.400 |
Why?
|
| Infant | 10 | 2021 | 3047 | 0.400 |
Why?
|
| Gene Deletion | 1 | 2012 | 329 | 0.400 |
Why?
|
| Lipoprotein(a) | 2 | 2009 | 28 | 0.390 |
Why?
|
| Respiratory Sounds | 3 | 2021 | 33 | 0.380 |
Why?
|
| Population Groups | 3 | 2014 | 41 | 0.380 |
Why?
|
| Sequence Analysis, DNA | 7 | 2015 | 853 | 0.370 |
Why?
|
| Homozygote | 7 | 2019 | 200 | 0.370 |
Why?
|
| Biomarkers | 5 | 2020 | 1718 | 0.360 |
Why?
|
| Olfactory Perception | 1 | 2010 | 21 | 0.360 |
Why?
|
| Child, Preschool | 10 | 2021 | 3613 | 0.360 |
Why?
|
| Interleukin-4 | 2 | 2009 | 127 | 0.350 |
Why?
|
| Receptors, Odorant | 1 | 2010 | 37 | 0.350 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 6509 | 0.350 |
Why?
|
| Multigene Family | 1 | 2010 | 202 | 0.340 |
Why?
|
| United States | 11 | 2024 | 6674 | 0.340 |
Why?
|
| Amish | 2 | 2019 | 6 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2008 | 79 | 0.330 |
Why?
|
| Antigens, Differentiation | 2 | 1999 | 141 | 0.320 |
Why?
|
| Marriage | 2 | 1999 | 26 | 0.320 |
Why?
|
| DNA | 5 | 2023 | 1294 | 0.320 |
Why?
|
| Family Characteristics | 2 | 2009 | 48 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2008 | 48 | 0.320 |
Why?
|
| Disease | 1 | 2008 | 90 | 0.320 |
Why?
|
| Immunoconjugates | 2 | 1999 | 106 | 0.320 |
Why?
|
| Protein Isoforms | 1 | 2009 | 270 | 0.310 |
Why?
|
| Evolution, Molecular | 3 | 2012 | 813 | 0.310 |
Why?
|
| Chromatin | 5 | 2021 | 380 | 0.310 |
Why?
|
| Interleukin-33 | 2 | 2021 | 24 | 0.310 |
Why?
|
| Intergenerational Relations | 1 | 2007 | 5 | 0.310 |
Why?
|
| CpG Islands | 3 | 2023 | 151 | 0.310 |
Why?
|
| Algorithms | 7 | 2019 | 1830 | 0.300 |
Why?
|
| Mothers | 3 | 2022 | 141 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 19 | 4 | 2012 | 59 | 0.300 |
Why?
|
| Social Isolation | 1 | 2007 | 67 | 0.300 |
Why?
|
| Base Sequence | 7 | 2010 | 2330 | 0.300 |
Why?
|
| Olfaction Disorders | 1 | 2008 | 62 | 0.290 |
Why?
|
| Cohort Studies | 8 | 2021 | 2767 | 0.290 |
Why?
|
| Glycoproteins | 1 | 2008 | 234 | 0.290 |
Why?
|
| Membrane Proteins | 4 | 2022 | 1196 | 0.290 |
Why?
|
| Placenta | 4 | 2021 | 175 | 0.290 |
Why?
|
| Smell | 2 | 2005 | 109 | 0.290 |
Why?
|
| T-Lymphocytes | 4 | 2020 | 1195 | 0.290 |
Why?
|
| Surveys and Questionnaires | 2 | 2011 | 2501 | 0.270 |
Why?
|
| Major Histocompatibility Complex | 2 | 2005 | 81 | 0.270 |
Why?
|
| Epigenomics | 2 | 2020 | 100 | 0.270 |
Why?
|
| Genetics, Medical | 1 | 2006 | 52 | 0.270 |
Why?
|
| Genes, X-Linked | 2 | 2021 | 37 | 0.270 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2005 | 11 | 0.270 |
Why?
|
| Child Day Care Centers | 1 | 2005 | 6 | 0.260 |
Why?
|
| Dust | 2 | 2023 | 26 | 0.260 |
Why?
|
| Triglycerides | 2 | 2003 | 232 | 0.260 |
Why?
|
| Aging | 2 | 2007 | 691 | 0.260 |
Why?
|
| Genes, MHC Class II | 2 | 2021 | 30 | 0.260 |
Why?
|
| Prevalence | 4 | 2017 | 1239 | 0.250 |
Why?
|
| Immune Tolerance | 2 | 2005 | 337 | 0.250 |
Why?
|
| Lipoproteins | 1 | 2005 | 135 | 0.250 |
Why?
|
| Common Cold | 2 | 2015 | 13 | 0.250 |
Why?
|
| Dermatomyositis | 1 | 2004 | 17 | 0.250 |
Why?
|
| Chimera | 1 | 2004 | 56 | 0.240 |
Why?
|
| Animals | 17 | 2023 | 26582 | 0.240 |
Why?
|
| Biometry | 1 | 2004 | 66 | 0.240 |
Why?
|
| Fetus | 3 | 2005 | 226 | 0.240 |
Why?
|
| Perception | 1 | 2005 | 168 | 0.230 |
Why?
|
| Multifactorial Inheritance | 2 | 2023 | 159 | 0.230 |
Why?
|
| Maternal-Fetal Exchange | 3 | 1999 | 76 | 0.230 |
Why?
|
| Receptors, Muscarinic | 1 | 2003 | 49 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2003 | 85 | 0.220 |
Why?
|
| HLA-DQ Antigens | 3 | 2004 | 52 | 0.220 |
Why?
|
| Gastrointestinal Tract | 2 | 2015 | 191 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2003 | 86 | 0.220 |
Why?
|
| Nasal Polyps | 1 | 2023 | 58 | 0.220 |
Why?
|
| Respiratory System | 2 | 2023 | 116 | 0.220 |
Why?
|
| Forced Expiratory Volume | 1 | 2023 | 122 | 0.220 |
Why?
|
| HLA-A Antigens | 4 | 1997 | 44 | 0.220 |
Why?
|
| Adult Children | 1 | 2022 | 12 | 0.220 |
Why?
|
| Coenzyme A | 1 | 2022 | 15 | 0.220 |
Why?
|
| Patient Acuity | 1 | 2022 | 33 | 0.210 |
Why?
|
| Eosinophils | 2 | 2019 | 194 | 0.210 |
Why?
|
| Carrier Proteins | 2 | 2017 | 673 | 0.210 |
Why?
|
| Dermatitis, Atopic | 2 | 2021 | 52 | 0.210 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2019 | 241 | 0.210 |
Why?
|
| Intellectual Disability | 3 | 2021 | 186 | 0.210 |
Why?
|
| Europe | 3 | 2017 | 309 | 0.210 |
Why?
|
| HLA-A2 Antigen | 1 | 2021 | 31 | 0.210 |
Why?
|
| Computational Biology | 2 | 2017 | 528 | 0.200 |
Why?
|
| Age of Onset | 2 | 2019 | 310 | 0.200 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2021 | 20 | 0.200 |
Why?
|
| B-Lymphocytes | 3 | 2014 | 724 | 0.200 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2021 | 6 | 0.200 |
Why?
|
| Genetic Pleiotropy | 1 | 2021 | 24 | 0.200 |
Why?
|
| Mucin 5AC | 1 | 2021 | 8 | 0.200 |
Why?
|
| Genetic Markers | 2 | 2019 | 476 | 0.200 |
Why?
|
| Odorants | 1 | 2002 | 70 | 0.200 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2021 | 54 | 0.200 |
Why?
|
| Amino Acids | 1 | 2022 | 252 | 0.200 |
Why?
|
| B7-H1 Antigen | 1 | 2023 | 250 | 0.200 |
Why?
|
| Fucosyltransferases | 1 | 2020 | 8 | 0.200 |
Why?
|
| Fetal Viability | 3 | 1998 | 9 | 0.200 |
Why?
|
| Genomics | 5 | 2024 | 720 | 0.190 |
Why?
|
| Histocompatibility Testing | 2 | 1998 | 154 | 0.190 |
Why?
|
| Sequence Analysis, RNA | 2 | 2021 | 217 | 0.190 |
Why?
|
| Autoimmune Diseases | 3 | 2012 | 241 | 0.190 |
Why?
|
| ABO Blood-Group System | 1 | 2020 | 62 | 0.190 |
Why?
|
| Pneumococcal Infections | 1 | 2020 | 46 | 0.190 |
Why?
|
| Epistasis, Genetic | 1 | 2020 | 86 | 0.190 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 32 | 0.190 |
Why?
|
| Adipocytes | 1 | 2021 | 155 | 0.180 |
Why?
|
| TRPV Cation Channels | 1 | 2020 | 15 | 0.180 |
Why?
|
| HLA-DRB1 Chains | 1 | 2020 | 28 | 0.180 |
Why?
|
| Aspergillus fumigatus | 1 | 2020 | 18 | 0.180 |
Why?
|
| Inbreeding Depression | 1 | 2019 | 2 | 0.180 |
Why?
|
| Rhinitis, Allergic | 1 | 2020 | 43 | 0.180 |
Why?
|
| Gene Ontology | 1 | 2019 | 34 | 0.180 |
Why?
|
| V(D)J Recombination | 1 | 2019 | 10 | 0.180 |
Why?
|
| Fetal Growth Retardation | 1 | 2000 | 66 | 0.180 |
Why?
|
| Inheritance Patterns | 2 | 2012 | 48 | 0.180 |
Why?
|
| Urban Population | 1 | 2021 | 213 | 0.180 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2019 | 15 | 0.180 |
Why?
|
| Risk | 4 | 2017 | 674 | 0.180 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 132 | 0.180 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 37 | 0.180 |
Why?
|
| Serine Endopeptidases | 1 | 2020 | 145 | 0.170 |
Why?
|
| Transcription Factors | 3 | 2021 | 1565 | 0.170 |
Why?
|
| Taboo | 1 | 1999 | 1 | 0.170 |
Why?
|
| Body Size | 1 | 2019 | 91 | 0.170 |
Why?
|
| Cell Line | 3 | 2021 | 2468 | 0.170 |
Why?
|
| Computer Simulation | 3 | 2005 | 1078 | 0.170 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 1999 | 19 | 0.170 |
Why?
|
| Sexual Behavior | 1 | 2002 | 302 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1999 | 51 | 0.170 |
Why?
|
| Cells, Cultured | 4 | 2020 | 2818 | 0.170 |
Why?
|
| Adipose Tissue | 1 | 2021 | 240 | 0.170 |
Why?
|
| Fungi | 1 | 2019 | 65 | 0.170 |
Why?
|
| Smoking | 1 | 2023 | 609 | 0.170 |
Why?
|
| Risk-Taking | 1 | 2019 | 148 | 0.160 |
Why?
|
| Endocrine System | 1 | 2018 | 17 | 0.160 |
Why?
|
| Kallikreins | 2 | 2012 | 47 | 0.160 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 371 | 0.160 |
Why?
|
| Monocytes | 1 | 1999 | 214 | 0.160 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1999 | 170 | 0.160 |
Why?
|
| Environmental Exposure | 2 | 2019 | 296 | 0.160 |
Why?
|
| Exons | 3 | 2012 | 450 | 0.160 |
Why?
|
| Neutrophils | 1 | 2019 | 307 | 0.160 |
Why?
|
| Interleukin-12 | 1 | 2018 | 108 | 0.160 |
Why?
|
| Interleukin-2 | 1 | 2018 | 249 | 0.150 |
Why?
|
| Pregnancy, Ectopic | 1 | 1998 | 36 | 0.150 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2016 | 456 | 0.150 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 536 | 0.150 |
Why?
|
| Health Status | 1 | 2019 | 360 | 0.150 |
Why?
|
| Immunity | 1 | 2018 | 136 | 0.150 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 2705 | 0.150 |
Why?
|
| Chronic Disease | 3 | 2023 | 971 | 0.150 |
Why?
|
| Lymphocytes | 2 | 2018 | 464 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 258 | 0.150 |
Why?
|
| Genes, Lethal | 2 | 2015 | 53 | 0.140 |
Why?
|
| Birth Rate | 3 | 2012 | 12 | 0.140 |
Why?
|
| Christianity | 3 | 2016 | 36 | 0.140 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2016 | 38 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 927 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2018 | 689 | 0.140 |
Why?
|
| Embryonic and Fetal Development | 1 | 1995 | 72 | 0.130 |
Why?
|
| Transplantation, Homologous | 1 | 1998 | 996 | 0.130 |
Why?
|
| Embryo Loss | 1 | 2015 | 4 | 0.130 |
Why?
|
| Exome | 2 | 2012 | 127 | 0.130 |
Why?
|
| Cognition | 1 | 2019 | 570 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
| Meta-Analysis as Topic | 2 | 2012 | 87 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 301 | 0.130 |
Why?
|
| Freezing | 1 | 2014 | 33 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 683 | 0.130 |
Why?
|
| Herpesvirus 4, Human | 2 | 2014 | 114 | 0.120 |
Why?
|
| Pregnancy Outcome | 3 | 2001 | 247 | 0.120 |
Why?
|
| Molecular Sequence Data | 4 | 2005 | 3030 | 0.120 |
Why?
|
| Religion | 3 | 2012 | 87 | 0.120 |
Why?
|
| HLA-D Antigens | 1 | 1993 | 20 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 740 | 0.120 |
Why?
|
| Likelihood Functions | 3 | 2005 | 251 | 0.120 |
Why?
|
| Metagenome | 1 | 2014 | 102 | 0.110 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 136 | 0.110 |
Why?
|
| Mice | 7 | 2023 | 11352 | 0.110 |
Why?
|
| Blood Pressure | 3 | 2005 | 1143 | 0.110 |
Why?
|
| Maternal Exposure | 1 | 2013 | 57 | 0.110 |
Why?
|
| NADH Dehydrogenase | 1 | 2012 | 22 | 0.110 |
Why?
|
| Seasons | 1 | 2014 | 223 | 0.110 |
Why?
|
| Umbilical Cord | 1 | 2012 | 40 | 0.110 |
Why?
|
| Selection, Genetic | 1 | 1997 | 502 | 0.110 |
Why?
|
| Mutation Rate | 1 | 2012 | 48 | 0.110 |
Why?
|
| Untranslated Regions | 1 | 2012 | 19 | 0.110 |
Why?
|
| Autistic Disorder | 3 | 2012 | 147 | 0.110 |
Why?
|
| Lymphocyte Count | 1 | 2012 | 94 | 0.100 |
Why?
|
| Body Mass Index | 3 | 2015 | 770 | 0.100 |
Why?
|
| Bacteria | 1 | 2015 | 447 | 0.100 |
Why?
|
| Open Reading Frames | 1 | 2012 | 117 | 0.100 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2011 | 12 | 0.100 |
Why?
|
| Montana | 1 | 2011 | 8 | 0.100 |
Why?
|
| Synaptic Membranes | 1 | 2011 | 14 | 0.100 |
Why?
|
| Cell Transformation, Viral | 1 | 2011 | 40 | 0.100 |
Why?
|
| Chicago | 2 | 2012 | 1379 | 0.100 |
Why?
|
| Brain | 1 | 2021 | 2216 | 0.100 |
Why?
|
| Matched-Pair Analysis | 2 | 2001 | 43 | 0.100 |
Why?
|
| Software | 1 | 2015 | 654 | 0.100 |
Why?
|
| Interleukins | 1 | 2011 | 134 | 0.100 |
Why?
|
| Oxidoreductases | 1 | 2011 | 112 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 623 | 0.090 |
Why?
|
| Alternative Splicing | 2 | 2005 | 201 | 0.090 |
Why?
|
| Genes, Dominant | 2 | 2001 | 117 | 0.090 |
Why?
|
| Fertilization | 1 | 2010 | 40 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 3092 | 0.090 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2011 | 101 | 0.090 |
Why?
|
| Prostate-Specific Antigen | 1 | 2012 | 353 | 0.090 |
Why?
|
| Pheromones, Human | 1 | 2010 | 7 | 0.090 |
Why?
|
| Pan troglodytes | 2 | 2005 | 197 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 2011 | 286 | 0.090 |
Why?
|
| Chromosomes, Human, Y | 1 | 2009 | 22 | 0.090 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2015 | 455 | 0.090 |
Why?
|
| Kringles | 1 | 2009 | 6 | 0.090 |
Why?
|
| Logistic Models | 1 | 2013 | 1187 | 0.090 |
Why?
|
| Leukocyte Count | 2 | 2016 | 220 | 0.080 |
Why?
|
| Abatacept | 2 | 1999 | 83 | 0.080 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2008 | 9 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 428 | 0.080 |
Why?
|
| Recombination, Genetic | 2 | 2008 | 439 | 0.080 |
Why?
|
| CTLA-4 Antigen | 2 | 1999 | 135 | 0.080 |
Why?
|
| Lymphocyte Activation | 1 | 2011 | 728 | 0.080 |
Why?
|
| Adipokines | 1 | 2008 | 19 | 0.080 |
Why?
|
| Pulmonary Ventilation | 1 | 2008 | 32 | 0.080 |
Why?
|
| Family | 2 | 2007 | 311 | 0.080 |
Why?
|
| Crossing Over, Genetic | 1 | 2008 | 33 | 0.080 |
Why?
|
| Lectins | 1 | 2008 | 84 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 2 | 2012 | 297 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2005 | 307 | 0.080 |
Why?
|
| Binding Sites | 2 | 2007 | 1098 | 0.080 |
Why?
|
| 3' Untranslated Regions | 1 | 2007 | 92 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2008 | 348 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2008 | 219 | 0.080 |
Why?
|
| Antigens, CD | 2 | 1999 | 458 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 1801 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 1991 | 0.070 |
Why?
|
| Russia | 1 | 2006 | 25 | 0.070 |
Why?
|
| Germany | 1 | 2006 | 72 | 0.070 |
Why?
|
| Insulin | 2 | 2002 | 1160 | 0.070 |
Why?
|
| DNA-Cytosine Methylases | 1 | 2006 | 4 | 0.070 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2006 | 45 | 0.070 |
Why?
|
| Pseudogenes | 1 | 2005 | 35 | 0.070 |
Why?
|
| Endometrium | 2 | 2016 | 48 | 0.070 |
Why?
|
| Receptors, KIR2DL5 | 1 | 2005 | 1 | 0.070 |
Why?
|
| Phagocytes | 1 | 2005 | 10 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 279 | 0.070 |
Why?
|
| Histocompatibility | 1 | 1985 | 71 | 0.070 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2005 | 95 | 0.070 |
Why?
|
| Azacitidine | 1 | 2006 | 137 | 0.070 |
Why?
|
| Interferon-beta | 1 | 2006 | 125 | 0.070 |
Why?
|
| Human Body | 1 | 2005 | 6 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2005 | 210 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2006 | 1981 | 0.060 |
Why?
|
| HLA-DQ alpha-Chains | 2 | 1995 | 16 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1985 | 158 | 0.060 |
Why?
|
| DNA-Binding Proteins | 3 | 2021 | 1208 | 0.060 |
Why?
|
| Protein Precursors | 1 | 2005 | 143 | 0.060 |
Why?
|
| Maternal Age | 2 | 2008 | 44 | 0.060 |
Why?
|
| Antigen-Presenting Cells | 1 | 2005 | 139 | 0.060 |
Why?
|
| Receptors, Immunologic | 1 | 2005 | 135 | 0.060 |
Why?
|
| North America | 2 | 2011 | 180 | 0.060 |
Why?
|
| Virus Diseases | 1 | 2005 | 97 | 0.060 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2024 | 4 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 3640 | 0.060 |
Why?
|
| Animals, Domestic | 1 | 2004 | 12 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 1565 | 0.060 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2004 | 23 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 1041 | 0.060 |
Why?
|
| Incidence | 1 | 2008 | 1577 | 0.060 |
Why?
|
| Breast Feeding | 1 | 2005 | 91 | 0.060 |
Why?
|
| P-Selectin | 1 | 2003 | 13 | 0.060 |
Why?
|
| Chromosomes, Human | 1 | 2003 | 66 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2004 | 90 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2023 | 88 | 0.060 |
Why?
|
| Metabolomics | 1 | 2024 | 68 | 0.060 |
Why?
|
| Killer Cells, Natural | 1 | 2005 | 267 | 0.060 |
Why?
|
| Cockroaches | 1 | 2003 | 10 | 0.060 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2003 | 12 | 0.060 |
Why?
|
| Skin Tests | 1 | 2003 | 44 | 0.060 |
Why?
|
| Tandem Repeat Sequences | 1 | 2003 | 26 | 0.060 |
Why?
|
| Sheep | 1 | 2023 | 239 | 0.060 |
Why?
|
| Feces | 2 | 2015 | 319 | 0.060 |
Why?
|
| Age Factors | 2 | 2021 | 1851 | 0.060 |
Why?
|
| Linear Models | 1 | 2004 | 421 | 0.060 |
Why?
|
| Parity | 2 | 1999 | 93 | 0.060 |
Why?
|
| Cattle | 1 | 2023 | 376 | 0.060 |
Why?
|
| Cell Line, Transformed | 2 | 2014 | 154 | 0.050 |
Why?
|
| Biodiversity | 2 | 2015 | 197 | 0.050 |
Why?
|
| Neurons | 2 | 2021 | 1546 | 0.050 |
Why?
|
| Africa, Western | 1 | 2002 | 10 | 0.050 |
Why?
|
| Cadherin Related Proteins | 1 | 2022 | 1 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2004 | 989 | 0.050 |
Why?
|
| Paternity | 1 | 2002 | 8 | 0.050 |
Why?
|
| Japan | 1 | 2022 | 307 | 0.050 |
Why?
|
| Proteomics | 1 | 2024 | 212 | 0.050 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2021 | 17 | 0.050 |
Why?
|
| Gigantism | 1 | 2021 | 3 | 0.050 |
Why?
|
| Genes, erbB-2 | 1 | 2021 | 24 | 0.050 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2021 | 11 | 0.050 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 21 | 0.050 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2021 | 21 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 674 | 0.050 |
Why?
|
| Fasting | 1 | 2002 | 161 | 0.050 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2021 | 34 | 0.050 |
Why?
|
| Food Preferences | 1 | 2021 | 26 | 0.050 |
Why?
|
| Interleukin-17 | 1 | 2022 | 101 | 0.050 |
Why?
|
| Electric Impedance | 1 | 2001 | 104 | 0.050 |
Why?
|
| Cadherins | 1 | 2022 | 151 | 0.050 |
Why?
|
| Hypothalamus | 1 | 2021 | 79 | 0.050 |
Why?
|
| Introns | 2 | 2014 | 289 | 0.050 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 76 | 0.050 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2021 | 41 | 0.050 |
Why?
|
| Decidua | 1 | 2020 | 19 | 0.050 |
Why?
|
| Prognosis | 1 | 2008 | 3680 | 0.050 |
Why?
|
| Streptococcus pneumoniae | 1 | 2020 | 48 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2021 | 74 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2021 | 132 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2020 | 4213 | 0.050 |
Why?
|
| Creatinine | 1 | 2001 | 338 | 0.050 |
Why?
|
| Bronchioles | 1 | 2020 | 1 | 0.050 |
Why?
|
| Cholesterol, HDL | 1 | 2001 | 165 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2021 | 209 | 0.050 |
Why?
|
| Calcineurin | 1 | 2020 | 16 | 0.050 |
Why?
|
| Phylogeny | 1 | 2005 | 1137 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 187 | 0.050 |
Why?
|
| Cholesterol, LDL | 1 | 2001 | 222 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2020 | 143 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2001 | 298 | 0.040 |
Why?
|
| Meiosis | 2 | 2012 | 80 | 0.040 |
Why?
|
| Lymphocyte Transfusion | 1 | 1999 | 41 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 2 | 1998 | 63 | 0.040 |
Why?
|
| Lipoproteins, HDL | 1 | 2000 | 96 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 193 | 0.040 |
Why?
|
| Eosinophilia | 1 | 2020 | 84 | 0.040 |
Why?
|
| Sample Size | 1 | 2000 | 130 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 286 | 0.040 |
Why?
|
| Gestational Age | 2 | 1999 | 311 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2020 | 129 | 0.040 |
Why?
|
| Avoidance Learning | 1 | 1999 | 16 | 0.040 |
Why?
|
| Stem Cells | 1 | 2021 | 351 | 0.040 |
Why?
|
| Zebrafish | 1 | 2021 | 309 | 0.040 |
Why?
|
| Comorbidity | 1 | 2022 | 943 | 0.040 |
Why?
|
| Calcium Channels | 1 | 2020 | 182 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 351 | 0.040 |
Why?
|
| Mesoderm | 1 | 1999 | 108 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2021 | 324 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 1998 | 51 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 164 | 0.040 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1998 | 11 | 0.040 |
Why?
|
| Immunogenetics | 1 | 1998 | 9 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2001 | 7993 | 0.040 |
Why?
|
| Histone Code | 1 | 2017 | 19 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 1540 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 1998 | 303 | 0.040 |
Why?
|
| Codon | 1 | 1997 | 124 | 0.040 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1997 | 29 | 0.040 |
Why?
|
| Point Mutation | 1 | 1998 | 246 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2000 | 999 | 0.040 |
Why?
|
| DNA Primers | 1 | 1998 | 543 | 0.040 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2017 | 179 | 0.040 |
Why?
|
| Gorilla gorilla | 1 | 1997 | 41 | 0.040 |
Why?
|
| Lod Score | 2 | 2008 | 152 | 0.040 |
Why?
|
| Disease Progression | 1 | 2021 | 1531 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 49 | 0.040 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2016 | 47 | 0.040 |
Why?
|
| Phospholipase D | 1 | 2015 | 12 | 0.030 |
Why?
|
| Fibroblasts | 1 | 1999 | 729 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2016 | 148 | 0.030 |
Why?
|
| Integrin alpha2 | 1 | 2015 | 2 | 0.030 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2015 | 5 | 0.030 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2015 | 9 | 0.030 |
Why?
|
| STAT2 Transcription Factor | 1 | 2015 | 6 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 263 | 0.030 |
Why?
|
| Luteal Phase | 1 | 2015 | 14 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1458 | 0.030 |
Why?
|
| Survival Analysis | 1 | 1999 | 1538 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2015 | 111 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 1999 | 1823 | 0.030 |
Why?
|
| Nedd4 Ubiquitin Protein Ligases | 1 | 2014 | 14 | 0.030 |
Why?
|
| Transformation, Genetic | 1 | 2014 | 40 | 0.030 |
Why?
|
| HLA-B Antigens | 2 | 1985 | 35 | 0.030 |
Why?
|
| Birth Intervals | 2 | 1985 | 7 | 0.030 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2014 | 15 | 0.030 |
Why?
|
| Interferon Regulatory Factors | 1 | 2015 | 67 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 39 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2014 | 96 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 1999 | 1753 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 920 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2014 | 69 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 1047 | 0.030 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2013 | 14 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 171 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 165 | 0.030 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2013 | 23 | 0.030 |
Why?
|
| Models, Molecular | 1 | 1997 | 1286 | 0.030 |
Why?
|
| Temperature | 1 | 2014 | 396 | 0.030 |
Why?
|
| Semen | 1 | 2012 | 13 | 0.030 |
Why?
|
| Sperm Motility | 1 | 2012 | 11 | 0.030 |
Why?
|
| Centromere | 1 | 2012 | 26 | 0.030 |
Why?
|
| Canada | 1 | 2012 | 204 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2014 | 678 | 0.030 |
Why?
|
| Caribbean Region | 1 | 2011 | 20 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2012 | 68 | 0.030 |
Why?
|
| Telomere | 1 | 2012 | 108 | 0.020 |
Why?
|
| Fathers | 1 | 2012 | 70 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 1621 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 526 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 155 | 0.020 |
Why?
|
| Viral Load | 1 | 2011 | 148 | 0.020 |
Why?
|
| Methionine | 1 | 2010 | 66 | 0.020 |
Why?
|
| Emigration and Immigration | 1 | 2009 | 48 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 2232 | 0.020 |
Why?
|
| RNA | 1 | 2013 | 560 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2012 | 575 | 0.020 |
Why?
|
| Paternal Age | 1 | 2008 | 5 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2008 | 45 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2015 | 919 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2007 | 55 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2006 | 148 | 0.020 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 1 | 2005 | 18 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 1985 | 61 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2005 | 49 | 0.020 |
Why?
|
| Markov Chains | 1 | 2005 | 125 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2005 | 229 | 0.020 |
Why?
|
| Ultrasonography | 1 | 1987 | 695 | 0.020 |
Why?
|
| Contraception | 1 | 1985 | 88 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2015 | 3241 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 364 | 0.010 |
Why?
|
| Cats | 1 | 2004 | 303 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2004 | 149 | 0.010 |
Why?
|
| Genetic Techniques | 1 | 2003 | 72 | 0.010 |
Why?
|
| Food Hypersensitivity | 1 | 2004 | 63 | 0.010 |
Why?
|
| Dogs | 1 | 2004 | 685 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 712 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 238 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2002 | 79 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2002 | 100 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 2426 | 0.010 |
Why?
|
| Austria | 1 | 1989 | 19 | 0.010 |
Why?
|
| Inbreeding | 1 | 1989 | 45 | 0.010 |
Why?
|
| Probability | 1 | 1989 | 355 | 0.010 |
Why?
|
| Fetal Death | 1 | 1987 | 56 | 0.000 |
Why?
|